Final Programme PDF

Click here to download the preliminary programme as a PDF

Thursday, June 23, 2022

10:30
12:00
Executive Board Meeting
     
12:00 13:00 Lunch Symposium Novo Nordisk 1
   
13:10 13:30 Opening Ceremony Thomas Stulnig: CEDA President & President of the Organizing Committee
      Michael Binder: CMO Vienna Health Care Group
      Representative of the Mayor of the City of Vienna
      Markus Müller: Rektor of the Medical University of Vienna
13:30
14:15
Keynote Lecture
Chair 1: Thomas Stulnig
AT
 
      Chair 2: Christian Herder
DE
 
      Michael Roden DE Precision diabetes medicine based on individualized subtyping
      Discussion
   
14:15 15:45 Scientific Session I: New technologies
Chair 1: Tadej Battelino
SLO
 
      Chair 2: Ingrid Schütz-Fuhrmann
AT
 
      Ingrid Schütz-Fuhrmann
AT
DIY – Do It Yourself Looping
      Christophe de Block
BE
Long-term implantatable sensors
      Tadej Battelino
SLO
CGM in type 2 diabetes: therapy-intensifying tool
      Moshe Phillip
IL
Artificial intelligence advisors/clinical decision support
      Discussion
   
15:45 16:15 Snack Symposium Dexcom
16:15 16:30 Coffee Time
16:30 18:00
Scientific Session II: Diabetes and cardiovascular disease Chair 1: Nebojsa Lalic RS
    Chair 2: Jan Skrha CZ
    Tomasz Klupa PL Cardiovascular disease in Type 1 and early-onset Type 2 diabetes
    Nebojsa Lalic RS Comparison of antidiabetic drugs for CVD prevention
    Maciej Banach PL Upcoming treatments for Diabetic Dyslipidemia
    Clemens von Schacky DE Are omega 3 fatty acids still effective?
    Discussion
18:00 19:00
Evening Symposium AstraZeneca
19:00
20:00
CEDA Welcome Evening

Friday, June 24, 2022

08:00 09:00 Breakfast Symposium Eli Lilly
09:00 10:00 Session III: Diabetes and the heart Chair 1: Martin Clodi AT
Chair 2: Julia Szendrödi DE
Martin Clodi AT Diagnosis and risk of hear failure in diabetes
Eberhard Standl DE Antidiabetic drugs with positive and negative impact on heart failure
Diana Bonderman AT Treatment of HFrEF, HFmrEF, HFpEF
Discussion
10:00 10:20 Coffee Time  
10:20 11:20 Scientific Session IV: Diabetic Neuropathy Chair 1: Peter Kempler HU
Chair 2: Ilze Konrade LTV
Dan Ziegler DE New consensus recommendations on the management of diabetic polyneuropathy in clinical practice
Solomon Tesfaye UK Management of peripheral DNP
Vincenza Spallone IT Clinical approach to diabetic autonomic neuropathy
Anna Körei HU Why only four tests for the diagnosis of autonomic neuropathy?
Discussion
11:20 12:00 Rapid Fire Session: Pitchings of Scientific Abstracts Chair 1: Christian Herder DE
Chair 2: Anca Stoian RO
12:00 14:00 Poster Viewing
    Poster Session 1: CVD, Heart, Kidney
Chair: Manfredi Rizzo IT
    Poster Session 2: Neuropathy, Prevention, Health Service Access
Chair: Anna Körei HU
    Poster Session 3: New Technologies
Chair: Latife Bozkurt AT
    Poster Session 4: Other topics
Chair: Roger Lehmann
CH
12:15 13:45 Lunch Symposium Novo Nordisk 2
14:00
15:30 Scientific Session V: Novel approaches to diabetes treatment Chair: Julia Szendrödi DE
  Chair 2: Roger Lehmann CH
  Christian Herder DE Anti-inflammatory treatments to prevent diabetes complications
  Tsvetalina Tankova BG Developing strategies against diabetic foot ulcerations
  Patricia Zaharia DE Biomarkers for improved classification of diabetes
  Erifili Hatziagelaki GR Novel insulin analogues: a step forward or more of the same?
  Discussion
15:30
16:00
Snack Symposium Viatris
16:00
16:30
Coffee Time
16:30
18:00
Scientific Session VI: Diabetes prevention Chair 1: Tomasz Klupa PL
    Chair 2: Latife Bozkurt AT
    Anca Stoian RO Microbiota and Diabetes – a tightening connection
    Othmar Moser AT Sports for all?
    Sofiya Gancheva DE Bariatric surgery to prevent diabetes?
    Nanette Schloot DE Drugs for the prevention of type 1 diabetes?
    Discussion
18:00 19:00 Evening Symposium Boehringer-Ingelheim
19:30
22:30
CEDA Networking Evening incl. Award Ceremony

Saturday, June 25, 2022

08:00 09:00 Breakfast Symposium Sanofi-Aventis
09:00 09:50 Keynote Lecture Chair 1: Thomas Stulnig AT
Chair 2: Peter Kempler HU
Robert Wagner
DE
The future of Incretin-based Therapies
Discussion
09:50 11:20 How to Improve Therapeutic Adherence (Interactive Workshop held in German, preregistration required, limited to 20 participants)
Ulrike Stulnig AT
09:50 10:50 Session VII: Big Questions in Diabetes Medicine Chair 1: Werner Waldhäusl AT
Chair 2: Tomasz Klupa PL
Manfredi Rizzo IT A novel syndemic approach to cardiometabolic disease during COVID-19 era: experience from the CAPISCO international panel
Stefan Thurner AT Big data – their impact on diabetes prevention and treatment
Discussion
10:50 11:10 Coffee Time
11:10 11:40 Snack Symposium Novartis
11:40 12:40 Pro&Con on Hot Topics in Clinical Diabetology Chair 1: Peter Diem CH
Chair 2: TBA
Latife Bozkurt AT PRO: SGBM is out of date
Roger Lehmann CH CON: SGBM is out of date
Replies
Heinz Drexler AT PRO: RCT rather than RWE data is relevant for clinical practice
Helmut Brath AT CON: RCT rather than RWE data is relevant for clinical practice
Replies
Slobodan Peric AT PRO: Anti-obesity drugs rather than bariatric surgery should be used for weight loss
Bianca Itariu AT CON: Anti-obesity drugs rather than bariatric surgery should be used for weight loss
Replies
12:40 13:00 Closing Ceremony Thomas Stulnig AT
Peter Kempler HU
13:00 14:00 General Assembly Meeting
13:00 15:00 Farewell

Language

The official language of the congress will be English (no simultaneous translation)

Final Programme PDF

Click here to download the preliminary programme as a PDF